FIP/AAPS guidelines for dissolution/In vitro release testing of novel/special dosage forms

Martin Siewert; Jennifer Dressman; Cynthia Brown; Vinod Shah; Jean Marc Aiache; Nobuo Aoyagi; Dennis Bashaw; William Brown; Diane Burgess; John Crison; Patrick DeLuca; Ruzica Djerki; Thomas Foster; Kirsti Gjellan; Vivian Gray; Ajaz Hussain; Tom Ingallinera; James Klancke; Johannes Kraemer; Henning Kristensen; Kofi Kumi; Christian Leuner; Jobst Limberg; Petra Loos; Lenny Margulis; Patrick Marroum; Helga Moeller; Bernd Mueller; Martin Mueller-Zsigmondy; Ngozi Okafo; Larry Ouderkirk; Shravan Parsi; Saeed Qureshi; Joseph Robinson; Roger Williams

Journal ArticleOPEN ACCESS

FIP/AAPS guidelines for dissolution/In vitro release testing of novel/special dosage forms

Siewert M
Dressman J
Brown C
et al.

Dissolution Technologies (2003) 10(1) 6-15

DOI: 10.14227/DT100103P6

57Citations

129Readers

Cite

CITATION STYLE

APA

Siewert, M., Dressman, J., Brown, C., Shah, V., Aiache, J. M., Aoyagi, N., … Williams, R. (2003). FIP/AAPS guidelines for dissolution/In vitro release testing of novel/special dosage forms. Dissolution Technologies, 10(1), 6–15. https://doi.org/10.14227/DT100103P6

FIP/AAPS guidelines for dissolution/In vitro release testing of novel/special dosage forms

Cite

Register to see more suggestions